Can Cell and Gene Therapies Achieve Their Full Potential?

被引:0
|
作者
Shanley, Agnes
机构
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:41 / 43
页数:3
相关论文
共 50 条
  • [21] Gene and cell therapies in demand
    King, Anthony
    CHEMISTRY & INDUSTRY, 2019, 83 (05) : 8 - 8
  • [22] Gene and stem cell therapies
    Kaji, EH
    Leiden, JM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (05): : 545 - 550
  • [23] Industrializing Cell and Gene Therapies
    Shanley, Agnes
    BIOPHARM INTERNATIONAL, 2019, 32 (08) : 10 - +
  • [24] Gene and Cell Based Therapies
    Barker, R.
    MOVEMENT DISORDERS, 2010, 25 : S598 - S599
  • [25] Incretin-based therapies: can we achieve glycemic control and cardioprotection?
    Angeli, Franca S.
    Shannon, Richard P.
    JOURNAL OF ENDOCRINOLOGY, 2014, 221 (01) : T17 - T30
  • [26] Contributions of Gene Marking to Cell and Gene Therapies
    Barese, Cecilia N.
    Dunbar, Cynthia E.
    HUMAN GENE THERAPY, 2011, 22 (06) : 659 - 668
  • [27] How Health Information Technology Is Failing to Achieve Its Full Potential
    Carroll, Aaron E.
    JAMA PEDIATRICS, 2015, 169 (03) : 201 - 202
  • [28] The immune system can sabotage gene therapies - can scientists rein it in?
    Ledford, Heidi
    NATURE, 2024, 630 (8015) : 13 - 14
  • [29] How Can Radiopharmaceutical Therapies Reach Their Full Potential? Improving Dose Reporting and Phase I Clinical Trial Design
    Kiess, Ana P.
    O'Donoghue, Joseph
    Uribe, Carlos
    Bodei, Lisa
    Hobbs, Robert F.
    Hesterman, Jacob
    Kesner, Adam L.
    Sgouros, George
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (15)
  • [30] Value-based payment and financing for cell and gene therapies: challenges and potential solutions
    Zhang, James X.
    Shugarman, Lisa R.
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 678 - 681